Malaria Diagnostics Market to Grow at a Promising CAGR 5.1% by 2026, Exclusive Report

According to the report, the global malaria diagnostics industry was estimated at $728,870 thousand in 2018, and is expected to hit $1,085,106 thousand by 2026, registering a CAGR of 5.1% from 2019 to 2026.

Request Sample Copy of the Report:

https://www.alliedmarketresearch.com/request-sample/285

Key Takeaways:

The malaria diagnostics market refers to the global market for products and technologies used in diagnosing malaria infections.

The market is driven by the high prevalence of malaria in many parts of the world, particularly in regions such as Sub-Saharan Africa, Southeast Asia, and Latin America.

Rapid diagnostic tests (RDTs) are the most commonly used diagnostic method for malaria. They provide quick results and are relatively inexpensive.

Molecular diagnostics, such as polymerase chain reaction (PCR), are increasingly being adopted for malaria diagnosis due to their high sensitivity and ability to detect low-level infections.

The market is witnessing advancements in technology, including the development of automated diagnostic platforms and point-of-care devices, which improve testing accuracy and convenience.

Market Drivers:

High Prevalence of Malaria: Malaria remains a significant global health concern, especially in regions with high transmission rates, such as Sub-Saharan Africa, Southeast Asia, and Latin America. The high prevalence of malaria creates a demand for effective and accurate diagnostic tools.

Government and International Initiatives: Governments, non-profit organizations, and international bodies are actively involved in malaria control and elimination programs. These initiatives drive the demand for malaria diagnostics as part of comprehensive malaria control strategies.

Technological Advancements: The market is experiencing advancements in diagnostic technologies, including the development of rapid diagnostic tests (RDTs) and molecular diagnostics. These innovations offer improved sensitivity, specificity, and ease of use, enhancing the accuracy and efficiency of malaria diagnosis.

Market Segmentation:

Diagnostic Method: a. Rapid Diagnostic Tests (RDTs): These are simple, low-cost, and easy-to-use tests that detect malaria antigens in a patient's blood. b. Molecular Diagnostics: This includes techniques such as Polymerase Chain Reaction (PCR) that detect the presence of malaria parasites' DNA or RNA in the blood.

End User: a. Hospitals and Clinics: Diagnostic tests are performed in healthcare facilities, including hospitals and clinics, by trained healthcare professionals. b. Diagnostic Laboratories: Specialized laboratories conduct malaria diagnostic tests, particularly molecular diagnostics. c. Research Institutes: Research institutions play a role in developing and evaluating new diagnostic methods and technologies.

Request for Customization -

https://www.alliedmarketresearch.com/request-for-customization/285

Regional Growth Dynamics:

Based on geography, LAMEA contributed to 94% of the global malaria diagnostics market revenue in 2018, and is anticipated to maintain the lion's share till 2026. At the same time, the Asia-Pacific region would showcase the fastest CAGR of 6.1% during the study period. Surge in awareness regarding the use of antimalarial drugs in this region has propelled the growth. However, North America would register a CAGR of 4.1% by 2026.

Competitive Landscape:

Abbott Laboratories
BioMérieux SA
bioMérieux SA
Cepheid Inc. (a Danaher Corporation company)
Chembio Diagnostic Systems, Inc.
Meridian Bioscience, Inc.
Premier Medical Corporation Ltd.
QIAGEN N.V.
Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd)
Sysmex Corporation

Buy this Premium Research Report:

https://www.alliedmarketresearch.com/purchase-enquiry/285

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives

Browse more latest healthcare reports:

Novel Vaccine Delivery System Market https://www.alliedmarketresearch.com/novel-vaccine-delivery-systems-market-A11784

North America Workplace Wellness Market https://www.alliedmarketresearch.com/north-america-workplace-wellness-market-A12498

Chromatography Market https://www.alliedmarketresearch.com/chromatography-market-A13099

Infection Survillance Services Market https://www.alliedmarketresearch.com/infection-surveillance-services-market-A13109

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.